Clinical characteristics of multisystem inflammatory syndrome in adults: a systematic review
Importance Multisystem inflammatory syndrome in adults (MIS-A) has not been well
described. Improved diagnosis and treatment of MIS-A might mitigate COVID-19 morbidity …
described. Improved diagnosis and treatment of MIS-A might mitigate COVID-19 morbidity …
[HTML][HTML] Cognitive impact of COVID-19: looking beyond the short term
COVID-19 is primarily a respiratory disease but up to two thirds of hospitalised patients show
evidence of central nervous system (CNS) damage, predominantly ischaemic, in some …
evidence of central nervous system (CNS) damage, predominantly ischaemic, in some …
[HTML][HTML] Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity
O Cabral-Marques, G Halpert, LF Schimke… - Nature …, 2022 - nature.com
COVID-19 shares the feature of autoantibody production with systemic autoimmune
diseases. In order to understand the role of these immune globulins in the pathogenesis of …
diseases. In order to understand the role of these immune globulins in the pathogenesis of …
[HTML][HTML] Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: Results from the Brazilian COVID-19 registry
MS Marcolino, PK Ziegelmann… - International Journal of …, 2021 - Elsevier
Objectives To describe the clinical characteristics, laboratory results, imaging findings, and
in-hospital outcomes of COVID-19 patients admitted to Brazilian hospitals. Methods A cohort …
in-hospital outcomes of COVID-19 patients admitted to Brazilian hospitals. Methods A cohort …
Visceral fat is associated to the severity of COVID-19
G Favre, K Legueult, C Pradier, C Raffaelli, C Ichai… - Metabolism, 2021 - Elsevier
Background Excess visceral fat (VF) or high body mass index (BMI) is risk factors for severe
COVID-19. The receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
COVID-19. The receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
[HTML][HTML] Beyond erectile dysfunction: cGMP-specific phosphodiesterase 5 inhibitors for other clinical disorders
Cyclic guanosine monophosphate (cGMP), an important intracellular second messenger,
mediates cellular functional responses in all vital organs. Phosphodiesterase 5 (PDE5) is …
mediates cellular functional responses in all vital organs. Phosphodiesterase 5 (PDE5) is …
[HTML][HTML] COVID-19 and hypertension: the what, the why, and the how
It has been a year since the coronavirus disease 2019 (COVID-19) was declared pandemic
and wreak havoc worldwide. Despite meticulous research has been done in this period …
and wreak havoc worldwide. Despite meticulous research has been done in this period …
Double-blind, randomized, placebo-controlled trial with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by coronavirus disease 2019 …
JCG de Alencar, CL Moreira, AD Müller… - Clinical Infectious …, 2021 - academic.oup.com
Background A local increase in angiotensin 2 after inactivation of angiotensin-converting
enzyme 2 by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may induce a …
enzyme 2 by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may induce a …
[HTML][HTML] SNPs of ACE1 (rs4343) and ACE2 (rs2285666) genes are linked to SARS-CoV-2 infection but not with the severity of disease
N Alimoradi, M Sharqi, D Firouzabadi, MM Sadeghi… - Virology Journal, 2022 - Springer
COVID-19 and the renin-angiotensin system (RAS) are linked by angiotensin-converting
enzyme 2 (ACE2), a key enzyme in RAS that has been validated as a SARS-CoV-2 receptor …
enzyme 2 (ACE2), a key enzyme in RAS that has been validated as a SARS-CoV-2 receptor …
[HTML][HTML] Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations
PA Pousa, TSC Mendonça, EA Oliveira… - Jornal de …, 2021 - SciELO Brasil
Objective: The aim of this review was to summarize the most common extrapulmonary
manifestations in pediatric patients with COVID-19, as well as to discuss clinical …
manifestations in pediatric patients with COVID-19, as well as to discuss clinical …